|
14 Sep 2025 |
Max Healthcare
|
Consensus Share Price Target
|
1184.20 |
1249.13 |
- |
5.48 |
buy
|
|
|
|
|
07 Apr 2023
|
Max Healthcare
|
Motilal Oswal
|
1184.20
|
530.00
|
430.35
(175.17%)
|
Target met |
Buy
|
|
|
|
|
05 Feb 2023
|
Max Healthcare
|
Prabhudas Lilladhar
|
1184.20
|
500.00
|
435.50
(171.92%)
|
Target met |
Buy
|
|
|
|
|
03 Nov 2022
|
Max Healthcare
|
Prabhudas Lilladhar
|
1184.20
|
500.00
|
462.85
(155.85%)
|
Target met |
Buy
|
|
|
|
|
13 Aug 2022
|
Max Healthcare
|
Prabhudas Lilladhar
|
1184.20
|
427.00
|
396.85
(198.40%)
|
Target met |
Buy
|
|
|
|
|
11 Aug 2022
|
Max Healthcare
|
Edelweiss
|
1184.20
|
470.00
|
371.95
(218.38%)
|
Target met |
Buy
|
|
|
Continues to report robust performance
|
|
20 Jun 2022
|
Max Healthcare
|
Edelweiss
|
1184.20
|
470.00
|
362.40
(226.77%)
|
Target met |
Buy
|
|
|
Healthy ARPOB with improvement in occupancy
|
|
30 May 2022
|
Max Healthcare
|
Prabhudas Lilladhar
|
1184.20
|
427.00
|
380.35
(211.34%)
|
Target met |
Buy
|
|
|
|
|
27 May 2022
|
Max Healthcare
|
Edelweiss
|
1184.20
|
470.00
|
374.65
(216.08%)
|
Target met |
Buy
|
|
|
Mixed performance amid margin improvement
|
|
15 Feb 2022
|
Max Healthcare
|
Edelweiss
|
1184.20
|
470.00
|
371.60
(218.68%)
|
Target met |
Buy
|
|
|
In-line performance with robust pickup in non-covid business
|
|
15 Nov 2021
|
Max Healthcare
|
Edelweiss
|
1184.20
|
456.00
|
363.60
(225.69%)
|
Target met |
Buy
|
|
|
Strong performance with healthy pickup in non-covid business
|